Karin Pacheco
Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Occupational Exposure | 6 | 2020 | 263 | 2.140 |
Why?
| Hypersensitivity | 5 | 2020 | 272 | 1.890 |
Why?
| Allergens | 5 | 2019 | 427 | 1.680 |
Why?
| Dermatitis, Occupational | 2 | 2020 | 13 | 1.340 |
Why?
| Nickel | 3 | 2020 | 51 | 1.290 |
Why?
| Prostheses and Implants | 3 | 2021 | 141 | 1.240 |
Why?
| Air Pollutants, Occupational | 2 | 2020 | 32 | 1.070 |
Why?
| Arthroplasty, Replacement | 3 | 2021 | 45 | 1.050 |
Why?
| Dermatitis, Allergic Contact | 2 | 2018 | 63 | 1.000 |
Why?
| Occupational Diseases | 2 | 2012 | 129 | 0.750 |
Why?
| HLA-DRB4 Chains | 1 | 2020 | 6 | 0.740 |
Why?
| Erythema | 1 | 2020 | 25 | 0.730 |
Why?
| Isocyanates | 1 | 2020 | 15 | 0.720 |
Why?
| Trace Elements | 1 | 2020 | 48 | 0.700 |
Why?
| HLA-DR Antigens | 1 | 2020 | 220 | 0.670 |
Why?
| Host vs Graft Reaction | 1 | 2019 | 1 | 0.670 |
Why?
| Dermatitis, Irritant | 1 | 2018 | 11 | 0.630 |
Why?
| Patch Tests | 4 | 2021 | 52 | 0.600 |
Why?
| Prosthesis Implantation | 1 | 2015 | 139 | 0.470 |
Why?
| Leukocytes, Mononuclear | 2 | 2023 | 503 | 0.410 |
Why?
| Dental Offices | 1 | 2011 | 1 | 0.410 |
Why?
| Asthma, Occupational | 1 | 2011 | 4 | 0.400 |
Why?
| Irritants | 1 | 2011 | 41 | 0.390 |
Why?
| Industry | 1 | 2011 | 66 | 0.380 |
Why?
| Medical Laboratory Personnel | 1 | 2010 | 7 | 0.370 |
Why?
| Asthma | 3 | 2012 | 2152 | 0.360 |
Why?
| Lipopolysaccharide Receptors | 1 | 2010 | 85 | 0.350 |
Why?
| Immunoglobulin E | 1 | 2011 | 363 | 0.350 |
Why?
| Bronchodilator Agents | 1 | 2011 | 251 | 0.350 |
Why?
| Endotoxins | 1 | 2010 | 208 | 0.340 |
Why?
| Epigenesis, Genetic | 1 | 2012 | 531 | 0.300 |
Why?
| Polymorphism, Genetic | 1 | 2010 | 632 | 0.290 |
Why?
| Prosthesis Failure | 2 | 2017 | 116 | 0.260 |
Why?
| Sarcoidosis | 1 | 2023 | 133 | 0.200 |
Why?
| Bone Cements | 1 | 2021 | 37 | 0.190 |
Why?
| Humans | 14 | 2023 | 115841 | 0.180 |
Why?
| Genome-Wide Association Study | 2 | 2023 | 1301 | 0.170 |
Why?
| Reoperation | 1 | 2021 | 526 | 0.160 |
Why?
| Gloves, Protective | 1 | 2018 | 2 | 0.160 |
Why?
| Rubber | 1 | 2018 | 8 | 0.160 |
Why?
| Flame Retardants | 1 | 2018 | 8 | 0.160 |
Why?
| Cosmetics | 1 | 2018 | 7 | 0.160 |
Why?
| Titanium | 1 | 2019 | 75 | 0.160 |
Why?
| Cellular Senescence | 1 | 2019 | 153 | 0.150 |
Why?
| Disinfectants | 1 | 2018 | 34 | 0.150 |
Why?
| Avoidance Learning | 1 | 2018 | 62 | 0.150 |
Why?
| Solvents | 1 | 2018 | 109 | 0.150 |
Why?
| Male | 9 | 2019 | 56101 | 0.150 |
Why?
| Host-Pathogen Interactions | 1 | 2019 | 296 | 0.140 |
Why?
| Adult | 6 | 2018 | 30782 | 0.130 |
Why?
| Practice Guidelines as Topic | 2 | 2015 | 1403 | 0.130 |
Why?
| Female | 8 | 2020 | 60045 | 0.130 |
Why?
| Epoxy Compounds | 1 | 2015 | 31 | 0.130 |
Why?
| Methacrylates | 1 | 2015 | 110 | 0.120 |
Why?
| Metals | 1 | 2015 | 110 | 0.120 |
Why?
| Adrenal Cortex Hormones | 1 | 2018 | 510 | 0.120 |
Why?
| Alleles | 2 | 2023 | 814 | 0.120 |
Why?
| Diagnosis, Differential | 1 | 2018 | 1358 | 0.120 |
Why?
| Skin | 1 | 2018 | 668 | 0.110 |
Why?
| Hematologic Tests | 1 | 2013 | 22 | 0.110 |
Why?
| Middle Aged | 5 | 2017 | 27063 | 0.110 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2019 | 511 | 0.110 |
Why?
| Aged | 4 | 2017 | 19282 | 0.100 |
Why?
| Young Adult | 2 | 2020 | 10501 | 0.100 |
Why?
| Workers' Compensation | 1 | 2011 | 27 | 0.100 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2017 | 965 | 0.100 |
Why?
| Forkhead Transcription Factors | 1 | 2012 | 170 | 0.100 |
Why?
| Forced Expiratory Flow Rates | 1 | 2010 | 12 | 0.090 |
Why?
| Workplace | 1 | 2011 | 222 | 0.090 |
Why?
| Immunologic Factors | 1 | 2011 | 219 | 0.090 |
Why?
| Tobacco Smoke Pollution | 1 | 2012 | 221 | 0.080 |
Why?
| Sensitivity and Specificity | 1 | 2013 | 1728 | 0.080 |
Why?
| Lymphocyte Activation | 1 | 2012 | 1056 | 0.080 |
Why?
| Disease Management | 1 | 2011 | 562 | 0.070 |
Why?
| Cell Proliferation | 1 | 2013 | 2196 | 0.070 |
Why?
| Reproducibility of Results | 1 | 2013 | 2813 | 0.070 |
Why?
| Cells, Cultured | 1 | 2013 | 3916 | 0.060 |
Why?
| Genotype | 1 | 2010 | 1843 | 0.060 |
Why?
| Mice | 2 | 2012 | 15067 | 0.060 |
Why?
| T-Lymphocytes | 1 | 2012 | 1754 | 0.060 |
Why?
| HLA-DR alpha-Chains | 1 | 2023 | 4 | 0.060 |
Why?
| HLA-DRB1 Chains | 1 | 2023 | 99 | 0.050 |
Why?
| Genetic Predisposition to Disease | 2 | 2023 | 2209 | 0.050 |
Why?
| Animals | 3 | 2017 | 32113 | 0.050 |
Why?
| Aged, 80 and over | 1 | 2013 | 6433 | 0.050 |
Why?
| Pulmonary Surfactant-Associated Protein A | 1 | 2019 | 25 | 0.040 |
Why?
| GTPase-Activating Proteins | 1 | 2019 | 72 | 0.040 |
Why?
| Pulmonary Surfactant-Associated Protein C | 1 | 2019 | 42 | 0.040 |
Why?
| Exoribonucleases | 1 | 2019 | 40 | 0.040 |
Why?
| ATP-Binding Cassette Transporters | 1 | 2019 | 123 | 0.040 |
Why?
| Telomere-Binding Proteins | 1 | 2019 | 88 | 0.040 |
Why?
| DNA Helicases | 1 | 2019 | 133 | 0.040 |
Why?
| Mucin-5B | 1 | 2019 | 185 | 0.040 |
Why?
| Telomerase | 1 | 2019 | 207 | 0.040 |
Why?
| Insecta | 1 | 2017 | 63 | 0.040 |
Why?
| Sequence Analysis, DNA | 1 | 2019 | 733 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 445 | 0.030 |
Why?
| Promoter Regions, Genetic | 1 | 2019 | 1129 | 0.030 |
Why?
| Logistic Models | 1 | 2019 | 1865 | 0.030 |
Why?
| Genetic Variation | 1 | 2019 | 891 | 0.030 |
Why?
| RNA | 1 | 2019 | 821 | 0.030 |
Why?
| Case-Control Studies | 1 | 2019 | 3056 | 0.030 |
Why?
| Adolescent | 1 | 2010 | 17943 | 0.030 |
Why?
| Cohort Studies | 1 | 2017 | 4960 | 0.020 |
Why?
|
|
Pacheco's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|